Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2008
02/14/2008WO2007146385A9 Albumin-bound protein/peptide complex as a biomarker for disease
02/14/2008WO2007146171A3 Purified high molecular weight adiponectin and uses thereof
02/14/2008WO2007141691A3 Microelectronic sensor device with washing means
02/14/2008WO2007140497A8 Virus-nanoarray
02/14/2008WO2007137149A3 Use of cathepsin k antagonists in bone production
02/14/2008WO2007131048A3 Chromoionphore and method of determining calcium ions
02/14/2008WO2007127262A3 Enantiomers of 2'-fluoralkyl-6-nitroquipazine as serotonin transporter positron emission tomography imaging agents and antidepressant therapeutics
02/14/2008WO2007124742A3 Device for determining the stiffness of flexible materials
02/14/2008WO2007116309A3 Diagnostic and therapeutic application of ctl and nk functionally selected cells
02/14/2008WO2007113668A3 Device for the removal of liquid samples from the storage tank
02/14/2008WO2007085958A3 Diagnosis, prognosis and screening for medicaments for treatment of myeloproliferative disorders using receptor protein tyrosine-phosphatase gamma (ptprg) as biomarker
02/14/2008WO2007084021A3 Compositions and methods for diagnosing hiv-2 infection
02/14/2008WO2007050777A3 Methods and compositions for diagnosing lung cancer with specific dna methylation patterns
02/14/2008WO2007010283A8 Serine beta-lactamase-like / d-ala carboxypeptidase-like protein
02/14/2008WO2006135309A9 Method and system for affinity analysis
02/14/2008WO2006116917A3 Devices and methods for sample collection and analysis
02/14/2008WO2005047936A3 Method for evaluating anti-contamination level on a surface of optical recording medium, the apparatus and the optical recording medium
02/14/2008WO2001068804A8 Nucleic acid sequences associated with aging, particularly skin aging
02/14/2008US20080040819 Methods of identifying agents for treatment of schizophrenia and related disorders
02/14/2008US20080040344 Sense Database
02/14/2008US20080040045 Methods of populating data structures for use in evolutionary simulations
02/14/2008US20080040044 System for cell-based screening
02/14/2008US20080040041 Measuring Device And Method For Measuring At Least One Environmental Parameter
02/14/2008US20080039816 Carbohydrate-Encapsulated Quantum Dots for Bilogical Imaging
02/14/2008US20080039656 Synthesis and Application of Procainamide Analogs for Use in an Immunoassay
02/14/2008US20080039535 Methods of identifying agents for treating neurological disorders
02/14/2008US20080039495 Diamine Beta2 Adrenergic Receptor Agonists
02/14/2008US20080039416 Methods for Treating Disease by Modulating an Osmotic Stress Pathway
02/14/2008US20080039413 Novel compositions and methods in cancer
02/14/2008US20080039411 Use Of Resistin Antisense Oligonucleotides And/Or Sirna Molecules In The Treatment Of Rheumatoid Arthritis
02/14/2008US20080039402 Peptides and Peptidomimetics Binding to Cd23
02/14/2008US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression
02/14/2008US20080039392 CRAC channel and modulator screening methods
02/14/2008US20080039386 vaccines; use for detecting a group B streptococcus serotype III, RDP III-3 strain; drug screen an agent for inhibiting adhesion of a group B streptococcal cell to a host cell
02/14/2008US20080039383 Methods and compositions for inhibiting ER-stress induced cholesterol/triglyceride accumulation
02/14/2008US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same
02/14/2008US20080039343 Randomly Ordered Arrays and Methods of Making and Using
02/14/2008US20080039338 Human antibodies as detection reagents
02/14/2008US20080039337 Method for Detection of Conformational Change of a Protein Immobilized on a Substrate
02/14/2008US20080039336 Methods of screening for trpm4 modulators of insulin secretion
02/14/2008US20080038845 Assay by osmotically induced separation and concentration of high-molecular detectable substances and a fluid microsystem for carrying out said assay
02/14/2008US20080038844 Method of Analyzing Nucleic Acids Using an Array of Encoded Beads
02/14/2008US20080038843 Method of diagnosing celiac disease
02/14/2008US20080038842 SLITRK1 mutations associated with disorders in the OCD spectrum
02/14/2008US20080038841 Biosensor
02/14/2008US20080038840 Fluorescent Method And Compounds To Monitor Protein-Lipid Binding
02/14/2008US20080038839 Fluid Delivery System And Method
02/14/2008US20080038838 Dioxin-Binding Material and Method of Detecting or Quantifying Dioxin
02/14/2008US20080038834 conducting a heat treatment of a biological fluid without causing substantial sedimentation, precipitation, denaturation, agglutination and gelation of fluid components; processed biological fluid comprising substantially quantitatively disintegrated cellular components
02/14/2008US20080038832 Method for Producing Molecularly Imprinted Polymers for the Recognition of Target Molecules
02/14/2008US20080038831 IL-23p40 Specific Immunoglobulin Derived Proteins, Compositions, Epitopes, Methods and Uses
02/14/2008US20080038830 Nano-particle biochip substrates
02/14/2008US20080038829 Process for the Determination of Lipoproteins in Body Fluids
02/14/2008US20080038828 using a hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters; protocols for monitoring the efficacy of patient hemostasis therapies
02/14/2008US20080038771 Quantifiable Internal Reference Standards for Immunohistochemistry and Uses Thereof
02/14/2008US20080038764 COMPOSITIONS, KIT AND ONE-STEP METHOD FOR MONITORING COMPOUNDS HAVING ANTI-FACTOR Xa AND/OR ANTI FACTOR IIa ACTIVITIES
02/14/2008US20080038763 Method for analyzing blood for lipoprotein components
02/14/2008US20080038762 Method for analyzing blood for lipoprotein components
02/14/2008US20080038761 Compositions and methods for detecting and quantifying toxic substances in disease states
02/14/2008US20080038760 Method for Detecting Anti-Transglutaminase Antibodies
02/14/2008US20080038759 Test strip for lateral flow assays
02/14/2008US20080038758 cell-mediated immunological diagnostic method; improved sensitivity, application in an early stage of the infection before increase of the specific antibody and to use large scale field application
02/14/2008US20080038757 Method for Rapidly and Conveniently Detecting Target Substances and Enzyme Immunological Kit Therefor
02/14/2008US20080038756 Botulinum toxin substrate comprising fluorphore and clostridial toxin recognition sequence for use in detecting clostridial protease activity
02/14/2008US20080038755 Cellspot applications
02/14/2008US20080038754 Biomarkers for Early Detection of Ovarian Cancer
02/14/2008US20080038753 Pharmaceutical manufacturing methods
02/14/2008US20080038752 Reagents for the detection of protein phosphorylation in c-Src signaling pathways
02/14/2008US20080038751 using conjugated polyelectrolytes to measure formation of amyloid fibrils
02/14/2008US20080038750 Multivalent Chelators for Modifying and Organizing of Target Molecules
02/14/2008US20080038749 equipped with a coating for verifying antigen/antibody reactions; includes a silicon substrate, interdigital electrode pair structure that is located on the silicon substrate; high sensitivity
02/14/2008US20080038748 Antibodies That Recognize Cutting Edge Within The Tgf-Beta Activation Controlling Region
02/14/2008US20080038745 Nucleotide analogs with six-membered rings
02/14/2008US20080038741 T1R taste receptors and genes encoding same
02/14/2008US20080038739 For use in foods, beverages, cosmetics and drugs
02/14/2008US20080038738 Detecting tumor biomarker in oral cancer
02/14/2008US20080038736 Methods and compositions for the diagnosis for early hepatocellular carcinoma
02/14/2008US20080038731 Diagnostics and therapeutic uses of topors
02/14/2008US20080038730 Diagnostic and Therapeutic Use of Kcnj6 for Alzheimer's Disease
02/14/2008US20080038729 Method For Monitoring The Progress Of Cancer
02/14/2008US20080038720 Biologically-Active Dna-Binding Sites and Related Methods
02/14/2008US20080038719 Nucleic Acid Composite Materials Made Sensors For The Analysis Of Nucleic Acid Modifying Factors
02/14/2008US20080038717 Enrichment method for variant proteins with altered binding properties
02/14/2008US20080038714 Instrument to Pneumatically Control Lab Cards and Method Thereof
02/14/2008US20080038712 Oligomer Probe Array with Improved Signal-to-Noise Ratio and Detection Sensitivity and Method of Manufacturing the Same
02/14/2008US20080038365 TRPC6 involved in glomerulonephritis
02/14/2008US20080038287 Method For Identification, Isolation and Production of Antigens to a Specific Pathogen
02/14/2008US20080038286 Glycosylated polypeptides produced in yeast mutants and methods of use thereof
02/14/2008US20080038285 Method for Identifying and Quantifying of Tumour-Associated
02/14/2008US20080038283 Methods of Evaluating Efficacy of an Immune Response by Assesing Alpha-1 Integrin Expression
02/14/2008US20080038282 Biotinylated MHC complexes and their uses
02/14/2008US20080038281 Model membrane systems
02/14/2008US20080038272 binds highly specifically and/or selectively to human receptors of the Frizzled family; hybridoma cell that produces the antibody
02/14/2008US20080038270 Antibody Specific For A Chondroitin Sulphate Epitope
02/14/2008US20080038269 Methods for detecting and treating kidney disease
02/14/2008US20080038268 Streptococcus Pyogenes Antigens
02/14/2008US20080038264 Compositions and methods for the treatment of immune related diseases
02/14/2008US20080038255 Splice Variant of Unc5h2
02/14/2008US20080038249 Treatment Of Neurodegenerative Diseases By The Use Of Laptm4a
02/14/2008US20080038248 Proteins Ligands For Nkg2d And Ul16 Receptors And Uses Thereof